Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis

Kanna Ishizuka1, Wataru Fujii2, Natsuho Azuma1

  • 1Laboratory of Molecular Immunology, Department of Animal Resource Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.

Insights

Myeloid-related protein 14 (MRP14) plays a dual role in leishmaniasis. While it exacerbates skin lesions in cutaneous leishmaniasis, it improves anemia and splenomegaly in visceral leishmaniasis.

Area of Science:

  • Immunology
  • Pathology
  • Molecular Biology

Background:

  • Myeloid-related protein 14 (MRP14) is an S100 calcium-binding protein found in neutrophils and macrophages.
  • Elevated MRP14 levels are linked to autoimmune and infectious diseases, indicating its role in pathogenesis.

Purpose of the Study:

  • To investigate the role of MRP14 in the pathology of cutaneous and visceral leishmaniasis.
  • To compare the effects of MRP14 depletion on different forms of leishmaniasis.

Main Methods:

  • Infection of wild-type and MRP14 knockout mice with Leishmania major (cutaneous leishmaniasis) and Leishmania donovani (visceral leishmaniasis).
  • Assessment of disease progression, lesion development, and clinical parameters such as anemia and organomegaly.

Main Results:

  • MRP14+ cells increased at infection sites in wild-type mice for both L. major and L. donovani.
  • MRP14 depletion worsened skin lesions in L. major infection.
  • MRP14 depletion improved anemia and splenomegaly but not hepatomegaly in L. donovani infection at 24 weeks.

Conclusions:

  • MRP14 has distinct roles in different forms of leishmaniasis.
  • MRP14 appears protective in cutaneous leishmaniasis but exacerbates certain symptoms in visceral leishmaniasis.